📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antimyeloperoxidase antibodies modulate inflammatory responses and activate profibrotic pathways in human monocytes. (2023)

First Author: Flórez-Barrós F

Attributed to: MICA: Myeloperoxidase inhibition as a potential therapy in anti-neutrophil cytoplasmic antibody vasculitis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jaut.2023.103060

PubMed Identifier: 37331172

Publication URI: http://europepmc.org/abstract/MED/37331172

Type: Journal Article/Review

Volume: 139

Parent Publication: Journal of autoimmunity

ISSN: 0896-8411